Tomocube, Inc.’s Post

📢 New 𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆 featured in our October newsletter! In collaboration with Okomera and the research team at Institut Gustave Roussy, our study highlights how Tomocube’s #holotomography technology, when integrated with Okomera’s droplet-based #microfluidics, enables detailed, label-free analysis of chemotherapy response in patient-derived organoids (PDOs). 📩 Read the full story in our newsletter 👇